Annual EBITDA:
-$215.24M-$9.56M(-4.65%)Summary
- As of today, DAWN annual EBITDA is -$215.24 million, with the most recent change of -$9.56 million (-4.65%) on December 31, 2024.
- During the last 3 years, DAWN annual EBITDA has fallen by -$142.70 million (-196.70%).
- DAWN annual EBITDA is now -1479.52% below its all-time high of -$13.63 million, reached on December 31, 2020.
Performance
DAWN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$23.31M+$10.70M(+31.46%)Summary
- As of today, DAWN quarterly EBITDA is -$23.31 million, with the most recent change of +$10.70 million (+31.46%) on September 30, 2025.
- Over the past year, DAWN quarterly EBITDA has dropped by -$53.69 million (-176.73%).
- DAWN quarterly EBITDA is now -126.83% below its all-time high of $86.88 million, reached on March 1, 2019.
Performance
DAWN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$162.07M-$53.69M(-49.55%)Summary
- As of today, DAWN TTM EBITDA is -$162.07 million, with the most recent change of -$53.69 million (-49.55%) on September 30, 2025.
- Over the past year, DAWN TTM EBITDA has increased by +$48.01 million (+22.85%).
- DAWN TTM EBITDA is now -190.19% below its all-time high of $179.70 million, reached on September 1, 2019.
Performance
DAWN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DAWN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -4.7% | -176.7% | +22.9% |
| 3Y3 Years | -196.7% | +41.0% | -28.8% |
| 5Y5 Years | -1343.9% | -563.2% | -1077.5% |
DAWN EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -196.7% | at low | -176.7% | +79.6% | -49.5% | +44.5% |
| 5Y | 5-Year | -1479.5% | at low | -176.7% | +79.6% | -1077.5% | +44.5% |
| All-Time | All-Time | -1479.5% | at low | -126.8% | +79.6% | -190.2% | +44.5% |
DAWN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$23.31M(+31.5%) | -$162.07M(-49.5%) |
| Jun 2025 | - | -$34.01M(+15.3%) | -$108.37M(+42.6%) |
| Mar 2025 | - | -$40.17M(+37.8%) | -$188.76M(+12.3%) |
| Dec 2024 | -$215.24M(-4.6%) | -$64.57M(-312.5%) | -$215.24M(-2.5%) |
| Sep 2024 | - | $30.38M(+126.6%) | -$210.08M(+28.0%) |
| Jun 2024 | - | -$114.40M(-71.6%) | -$291.80M(-28.8%) |
| Mar 2024 | - | -$66.65M(-12.2%) | -$226.57M(-10.2%) |
| Dec 2023 | -$205.68M(-40.5%) | -$59.41M(-15.7%) | -$205.68M(-8.9%) |
| Sep 2023 | - | -$51.34M(-4.4%) | -$188.83M(-6.7%) |
| Jun 2023 | - | -$49.16M(-7.4%) | -$177.03M(-7.6%) |
| Mar 2023 | - | -$45.77M(-7.5%) | -$164.45M(-12.3%) |
| Dec 2022 | -$146.38M(-101.8%) | -$42.56M(-7.7%) | -$146.43M(-16.4%) |
| Sep 2022 | - | -$39.53M(-8.1%) | -$125.79M(-19.3%) |
| Jun 2022 | - | -$36.59M(-31.9%) | -$105.44M(-25.2%) |
| Mar 2022 | - | -$27.74M(-26.5%) | -$84.25M(-16.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$72.54M(-432.4%) | -$21.92M(-14.2%) | -$72.54M(-43.3%) |
| Sep 2021 | - | -$19.19M(-24.7%) | -$50.62M(-44.9%) |
| Jun 2021 | - | -$15.39M(+4.0%) | -$34.94M(-60.2%) |
| Mar 2021 | - | -$16.04M(-356.2%) | -$21.82M(-231.6%) |
| Dec 2020 | -$13.63M(+8.6%) | - | - |
| Sep 2020 | - | -$3.52M(-55.3%) | $16.58M(-80.8%) |
| Jun 2020 | - | -$2.26M(-28.9%) | $86.40M(-5.0%) |
| Mar 2020 | - | -$1.75M(-107.3%) | $90.97M(-49.3%) |
| Dec 2019 | -$14.91M | - | - |
| Dec 2019 | - | $24.11M(-63.6%) | $179.60M(-0.1%) |
| Sep 2019 | - | $66.31M(+2780.5%) | $179.70M(+10.2%) |
| Jun 2019 | - | $2.30M(-97.4%) | $163.08M(-6.0%) |
| Mar 2019 | - | $86.88M(+258.8%) | $173.47M(+100.3%) |
| Dec 2018 | - | $24.22M(-51.3%) | $86.60M(+38.8%) |
| Sep 2018 | - | $49.69M(+291.3%) | $62.38M(+391.3%) |
| Jun 2018 | - | $12.70M | $12.70M |
FAQ
- What is Day One Biopharmaceuticals, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Day One Biopharmaceuticals, Inc.?
- What is Day One Biopharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Day One Biopharmaceuticals, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Day One Biopharmaceuticals, Inc.?
- What is Day One Biopharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Day One Biopharmaceuticals, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Day One Biopharmaceuticals, Inc.?
- What is Day One Biopharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Day One Biopharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of DAWN is -$215.24M
What is the all-time high annual EBITDA for Day One Biopharmaceuticals, Inc.?
Day One Biopharmaceuticals, Inc. all-time high annual EBITDA is -$13.63M
What is Day One Biopharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, DAWN annual EBITDA has changed by -$9.56M (-4.65%)
What is Day One Biopharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of DAWN is -$23.31M
What is the all-time high quarterly EBITDA for Day One Biopharmaceuticals, Inc.?
Day One Biopharmaceuticals, Inc. all-time high quarterly EBITDA is $86.88M
What is Day One Biopharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, DAWN quarterly EBITDA has changed by -$53.69M (-176.73%)
What is Day One Biopharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of DAWN is -$162.07M
What is the all-time high TTM EBITDA for Day One Biopharmaceuticals, Inc.?
Day One Biopharmaceuticals, Inc. all-time high TTM EBITDA is $179.70M
What is Day One Biopharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, DAWN TTM EBITDA has changed by +$48.01M (+22.85%)